| Dr William R Porter, MD | |
|
800 W Central Rd, Department Of Pathology, Arlington Heights, IL 60005-2349 | |
| (847) 618-6150 | |
| Not Available |
| Full Name | Dr William R Porter |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 15 Years |
| Location | 800 W Central Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336382720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 036135864 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Community Hospital 1 | Arlington heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arlington Ridge Pathology Sc | 2567441785 | 7 |
News Archive
The Tailwind, a new rehabilitation device that helps stroke survivors improve arm movement, even many years after their stroke, is now available on the eve of May as National Stroke Awareness Month. The exercise device empowers stroke survivors to become more independent and enables them to achieve the tasks of daily life.
SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that Excella GmbH in Feucht, Germany has met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and has been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs") and potent drug products.
The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.
Inter Press Service examines HIV in the Caribbean, where "the HIV burden varies considerably among and within countries" in the region. "'I think the prevention programs in many countries are not reaching the right people,' Michel de Groulards, regional program adviser of the UNAIDS Caribbean Regional Support Team, told IPS," the news service writes, adding, "One factor, de Groulards believed, may be that after 25 years of providing treatment, some countries have reached a plateau.
Study findings suggest that burn wound eschar-derived mesenchymal cells represent a population of multipotent stem cells, which could be a new resource for engineering approaches to heal burn wounds.
› Verified 6 days ago
| Entity Name | Arlington Ridge Pathology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699774059 PECOS PAC ID: 2567441785 Enrollment ID: O20040720000286 |
News Archive
The Tailwind, a new rehabilitation device that helps stroke survivors improve arm movement, even many years after their stroke, is now available on the eve of May as National Stroke Awareness Month. The exercise device empowers stroke survivors to become more independent and enables them to achieve the tasks of daily life.
SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that Excella GmbH in Feucht, Germany has met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and has been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs") and potent drug products.
The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.
Inter Press Service examines HIV in the Caribbean, where "the HIV burden varies considerably among and within countries" in the region. "'I think the prevention programs in many countries are not reaching the right people,' Michel de Groulards, regional program adviser of the UNAIDS Caribbean Regional Support Team, told IPS," the news service writes, adding, "One factor, de Groulards believed, may be that after 25 years of providing treatment, some countries have reached a plateau.
Study findings suggest that burn wound eschar-derived mesenchymal cells represent a population of multipotent stem cells, which could be a new resource for engineering approaches to heal burn wounds.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William R Porter, MD 800 W Central Rd, Department Of Pathology, Arlington Heights, IL 60005-2349 Ph: (847) 618-6150 | Dr William R Porter, MD 800 W Central Rd, Department Of Pathology, Arlington Heights, IL 60005-2349 Ph: (847) 618-6150 |
News Archive
The Tailwind, a new rehabilitation device that helps stroke survivors improve arm movement, even many years after their stroke, is now available on the eve of May as National Stroke Awareness Month. The exercise device empowers stroke survivors to become more independent and enables them to achieve the tasks of daily life.
SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that Excella GmbH in Feucht, Germany has met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and has been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs") and potent drug products.
The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.
Inter Press Service examines HIV in the Caribbean, where "the HIV burden varies considerably among and within countries" in the region. "'I think the prevention programs in many countries are not reaching the right people,' Michel de Groulards, regional program adviser of the UNAIDS Caribbean Regional Support Team, told IPS," the news service writes, adding, "One factor, de Groulards believed, may be that after 25 years of providing treatment, some countries have reached a plateau.
Study findings suggest that burn wound eschar-derived mesenchymal cells represent a population of multipotent stem cells, which could be a new resource for engineering approaches to heal burn wounds.
› Verified 6 days ago
Kishen S. Manglani, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-6150 Fax: 847-618-6159 | |
Richard P. Regan, M.D. Pathology Medicare: Medicare Enrolled Practice Location: Northwest Community Hospital / Pathology Department, 800 West Central Road, Arlington Heights, IL 60005 Phone: 847-618-6150 Fax: 847-618-6159 | |
Susan B. Kern, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-6150 Fax: 847-618-6159 | |
Jason Weiss, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-6150 Fax: 847-618-6159 | |
Bretta K. Warren, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-6150 Fax: 847-618-6159 |